Demographic or characteristic | Non-ventilator-associated (n = 48) | Ventilator-associated (n = 96) | pValue |
---|---|---|---|
 | n (% or IQRa) | ||
Age in year | 74 (54.8-81.8) | 74 (59.0-80.0) | 0.944 |
Gender, male | 40 (83.3) | 73 (76.0) | 0.43 |
Acquired in ICU | 12 (25.0) | 84 (87.5)b | <0.001 |
ICU admission after pneumonia | 19 (39.6)c | 86 (89.6) | <0.001 |
Days of hospitalization prior to bacteremia | 14.5 (3.2-3.6) | 22.5 (12.0-40.8) | 0.021 |
Comorbidity | Â | Â | Â |
  Charlson comorbidity score | 3 (2.0-5.0) | 3 (2.0-5.0) | 0.861 |
  Hypertension | 22 (45.8) | 47 (49.0) | 0.86 |
  Coronary artery disease | 14 (29.2) | 15 (15.6) | 0.091 |
  Congestive heart failure | 6 (12.5) | 19 (19.8) | 0.392 |
  Cerebral vascular disease | 7 (14.6) | 27 (28.1) | 0.111 |
  COPD | 12 (25.0) | 27 (28.1) | 0.842 |
  Non-COPD chronic lung disease | 5 (10.4) | 15 (15.6) | 0.551 |
  Alcohol | 3 (6.3) | 13 (13.5) | 0.302 |
  Liver cirrhosis | 4 (8.3) | 5 (5.2) | 0.481 |
  Chronic kidney disease | 15 (31.3) | 32 (33.3) | 0.95 |
  Type 2 diabetes | 10 (20.8) | 35 (36.5) | 0.086 |
  Collagen vascular disease | 4 (8.3) | 7 (7.3) | 1 |
  Usage of immunosuppressants | 18 (37.5) | 32 (33.3) | 0.757 |
  Usage of corticosteroids | 7(14.6) | 23 (24.0) | 0.276 |
  Neutropenia | 4 (8.3) | 7 (7.3) | 1 |
  Malignancy | 22 (45.8) | 28 (29.2) | 0.073 |
   Hematologic malignancy | 7 (14.6) | 6 (6.3) | 0.125 |
   Solid malignancy | 17 (35.4) | 23 (24.0) | 0.211 |
  Previous shock | 8 (16.7) | 27 (28.1) | 0.192 |
  Recent surgery | 8 (16.7) | 34 (35.4) | 0.032 |
  Trauma | 0 (0) | 4 (4.2) | 0.301 |
Proceduresd | Â | Â | Â |
  Abdominal drain | 1 (2.1) | 5 (5.2) | 0.658 |
  Arterial line | 5 (10.4) | 36 (37.5) | 0.001 |
  Central venous catheter | 22 (45.8) | 71 (74.0) | 0.002 |
  Pulmonary artery catheter | 6 (12.5) | 20 (20.8) | 0.319 |
  Foley catheter | 28 (58.3) | 78 (81.3) | 0.006 |
  Hemodialysis | 4 (8.3) | 10 (10.4) | 0.774 |
  Nasogastric tube | 35 (72.9) | 93 (96.9) | <0.001 |
  Thoracic drain | 0 (0) | 7 (7.3) | 0.095 |
  Total parental nutrition | 1 (2.1) | 8 (8.3) | 0.273 |
  Tracheostomy | 7 (14.6) | 16 (16.7) | 0.936 |
Shockd | 29 (60.4) | 58 (60.4) | 1 |
APACHE II scored | 24 (17.3-31.8) | 27 (21.3-34.8) | 0.015 |
Radiological features | Â | Â | Â |
  Bilateral radiologic involvement | 27 (56.3) | 81 (84.4) | 0.001 |
  Pleural effusion | 20 (41.7) | 32 (33.3) | 0.425 |
Appropriate antimicrobial therapy | 20 (41.7) | 28 (29.2) | 0.189 |
Combination antimicrobial therapy | 4 (8.3) | 7 (7.3) | 1 |
Outcome | Â | Â | Â |
  14-day mortality | 21 (43.8) | 30 (31.3) | 0.196 |